Group One Trading’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 3399 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2846 |
|
|
2024
Q2 | – | Sell |
-94
| Closed | -$1.84K | – | 2885 |
|
|
2024
Q1 | $1.84K | Sell |
94
-14
| -13% | -$274 | ﹤0.01% | 1510 |
|
|
2023
Q4 | $2.23K | Sell |
108
-33
| -23% | -$681 | ﹤0.01% | 1600 |
|
|
2023
Q3 | $4.49K | Sell |
141
-70
| -33% | -$2.23K | ﹤0.01% | 1526 |
|
|
2023
Q2 | $7.1K | Sell |
211
-301
| -59% | -$10.1K | ﹤0.01% | 1360 |
|
|
2023
Q1 | $21.3K | Buy |
+512
| New | +$21.3K | ﹤0.01% | 1189 |
|
|
2022
Q4 | – | Sell |
-1,464
| Closed | -$72K | – | 3010 |
|
|
2022
Q3 | $72K | Sell |
1,464
-1,339
| -48% | -$65.9K | ﹤0.01% | 1115 |
|
|
2022
Q2 | $110K | Buy |
2,803
+369
| +15% | +$14.5K | ﹤0.01% | 1048 |
|
|
2022
Q1 | $90K | Buy |
2,434
+573
| +31% | +$21.2K | ﹤0.01% | 1268 |
|
|
2021
Q4 | $182K | Buy |
+1,861
| New | +$182K | ﹤0.01% | 1236 |
|
|
2021
Q3 | – | Sell |
-2,773
| Closed | -$348K | – | 3002 |
|
|
2021
Q2 | $348K | Buy |
2,773
+1,727
| +165% | +$217K | ﹤0.01% | 925 |
|
|
2021
Q1 | $142K | Buy |
1,046
+582
| +125% | +$79K | ﹤0.01% | 1115 |
|
|
2020
Q4 | $42K | Sell |
464
-131
| -22% | -$11.9K | ﹤0.01% | 1181 |
|
|
2020
Q3 | $44K | Sell |
595
-1,176
| -66% | -$87K | ﹤0.01% | 1101 |
|
|
2020
Q2 | $151K | Buy |
1,771
+428
| +32% | +$36.5K | ﹤0.01% | 712 |
|
|
2020
Q1 | $97K | Buy |
+1,343
| New | +$97K | ﹤0.01% | 703 |
|
|
2019
Q3 | – | Sell |
-125
| Closed | -$7K | – | 1987 |
|
|
2019
Q2 | $7K | Hold |
125
| – | – | ﹤0.01% | 1059 |
|
|
2019
Q1 | $9K | Buy |
125
+72
| +136% | +$5.18K | ﹤0.01% | 1015 |
|
|
2018
Q4 | $4K | Buy |
53
+40
| +308% | +$3.02K | ﹤0.01% | 1222 |
|
|
2018
Q3 | $6K | Buy |
+13
| New | +$6K | ﹤0.01% | 1238 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 1883 |
|